Ascendis Announces Planned $400 Million Share Repurchase Program

Ascendis Pharma A/S announced that its Board of Directors has authorized a $400 million share repurchase program. The company will execute purchases through various methods including open market transactions and accelerated share repurchase agreements, with timing and amounts determined by market conditions and share price.